RVL Pharmaceuticals plc (RVLPQ)
USD 0.0
(900.0%)
USD 0.0
(900.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 85.94 Million USD | -8.95% |
| 2021 | 94.39 Million USD | 9.49% |
| 2020 | 86.21 Million USD | -31.22% |
| 2019 | 125.34 Million USD | 8.0% |
| 2018 | 116.06 Million USD | 17.77% |
| 2017 | 98.55 Million USD | 8.79% |
| 2016 | 90.58 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 16.82 Million USD | -8.99% |
| 2023 Q2 | 14.43 Million USD | -14.21% |
| 2022 Q4 | 18.48 Million USD | -13.37% |
| 2022 Q2 | 21.26 Million USD | -13.62% |
| 2022 FY | 85.94 Million USD | -8.95% |
| 2022 Q1 | 24.62 Million USD | -5.81% |
| 2022 Q3 | 21.33 Million USD | 0.33% |
| 2021 Q3 | 18.73 Million USD | 0.0% |
| 2021 FY | 94.39 Million USD | 9.49% |
| 2021 Q4 | 26.14 Million USD | 39.5% |
| 2020 FY | 86.21 Million USD | -31.22% |
| 2019 FY | 125.34 Million USD | 8.0% |
| 2018 FY | 116.06 Million USD | 17.77% |
| 2017 FY | 98.55 Million USD | 8.79% |
| 2016 FY | 90.58 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -6335.75% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -1604.567% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -190.816% |
| Nascent Biotech, Inc. | 2.22 Million USD | -3754.245% |
| Rebus Holdings, Inc. | 664 Thousand USD | -12843.524% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -130.69% |
| Qrons Inc. | 643.67 Thousand USD | -13252.194% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -21961.73% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -49.626% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -20585.763% |
| Skye Bioscience, Inc. | 13.54 Million USD | -534.395% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 0.968% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -1647.591% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -32737.777% |
| SQZ Biotechnologies Company | 85.61 Million USD | -0.381% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -2847.122% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -5622.422% |
| Mesoblast Limited | 5.9 Million USD | -1356.201% |
| Marizyme, Inc. | 19.23 Million USD | -346.703% |
| Genus plc | 147.7 Million USD | 41.811% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -878.958% |
| Pharming Group N.V. | 225.49 Million USD | 61.885% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -4095.089% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -6306.419% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -930.639% |
| ContraFect Corporation | 56.88 Million USD | -51.075% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -1849.453% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -5711.996% |
| IMV Inc. | 37.7 Million USD | -127.915% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -2980.072% |
| MultiCell Technologies, Inc. | 567.42 USD | -15146528.6% |
| ONE Bio Corp. | 6.44 Million USD | -1233.744% |
| Accustem Sciences Inc. | 3.74 Million USD | -2194.057% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -16056.229% |
| Q BioMed Inc. | 3.43 Million USD | -2400.853% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -247.744% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -3170.953% |
| Biomind Labs Inc. | 994.18 Thousand USD | -8544.795% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 13.475% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -4784.132% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -1179.321% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -4509.868% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 343880.0% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -436.813% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -4583.409% |
| GB Sciences, Inc. | 1.42 Million USD | -5950.296% |
| Alpha Cognition Inc. | 9.7 Million USD | -785.52% |
| HST Global, Inc. | 140.9 Thousand USD | -60894.131% |
| CSL Limited | 3.44 Billion USD | 97.508% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -7540.167% |
| Halberd Corporation | 74.84 Thousand USD | -114735.253% |
| Enzolytics Inc. | 2.17 Million USD | -3843.323% |
| Agentix Corp. | 1.37 Million USD | -6165.327% |
| Resverlogix Corp. | 12.71 Million USD | -576.093% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -2254.202% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 94.396% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -8132.28% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -3473.695% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -5341.778% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -2424.098% |
| AVAX Technologies, Inc. | 7.31 Million USD | -1075.676% |
| Zenith Capital Corp. | 8.94 Million USD | -861.031% |
| Genscript Biotech Corporation | 825.34 Million USD | 89.587% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -493241.37% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -3400.363% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -50011.073% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -4374.191% |
| Kadimastem Ltd | 2.41 Million USD | -3466.017% |
| Helix BioMedix, Inc. | 1.97 Million USD | -4258.191% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -690.881% |
| BioStem Technologies, Inc. | 22.97 Million USD | -274.084% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -47256.531% |
| LadRx Corporation | 3.81 Million USD | -2154.714% |
| Cell Source, Inc. | 4.32 Million USD | -1887.009% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -9206.342% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -9206.342% |
| NovAccess Global Inc. | 2.46 Million USD | -3384.124% |
| Affymax, Inc. | 39.38 Million USD | -118.212% |
| Itoco Inc. | 919.14 Thousand USD | -9250.558% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -1927.763% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -7580.518% |
| Mobile Lads Corp. | 554.54 Thousand USD | -15398.263% |
| CytoDyn Inc. | 18.05 Million USD | -375.939% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -341371.652% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -38952.063% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -5953.351% |
| SYBLEU INC | 160.87 Thousand USD | -53323.133% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -4631.82% |
| International Stem Cell Corporation | 5.27 Million USD | -1530.526% |
| Bioxytran, Inc. | 3.82 Million USD | -2149.783% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -163163.174% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -422379.477% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -136.985% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -5211.805% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -11579.928% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -2662.617% |
| Neutra Corp. | 243.82 Thousand USD | -35149.22% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -392.324% |
| PureTech Health plc | 144.59 Million USD | 40.562% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -319.451% |
| IXICO plc | 4.7 Million USD | -1725.898% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -876.981% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 27.009% |
| CSL Limited | 3.89 Billion USD | 97.792% |
| Cellectis S.A. | 97.32 Million USD | 11.688% |